Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00399776 · ClinicalTrials.gov registry record
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 60
- Enrollment target
NCT00399776 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 60 participants.
The verdict
NCT00399776 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
We hypothesize that antipsychotic induced hyperprolactinemia can decrease bone mineral accrual and decrease bone mineral content (BMC) in adolescents on antipsychotic therapy. Specifics Aims 1. To determine if antipsychotic therapy leads to decreased bone mineral accrual and decreased bone mineral content in a group of adolescents on antipsychotic therapy by comparing them to an ethnicity, gender and pubertal stage matched control group. 2. To determine the relationship between serum concentrations of prolactin, sex steroids and bone turnover markers in adolescents on antipsychotic therapy and an ethnicity, gender and pubertal stage matched control group.
Interventions
- RADIATION Bone Density Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-10 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00399776
The ClinicalTrials.gov registry entry for NCT00399776 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone Density Test is the first listed.
NCT00399776 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00399776 about?
NCT00399776 is a clinical study titled "Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy". We hypothesize that antipsychotic induced hyperprolactinemia can decrease bone mineral accrual and decrease bone mineral content (BMC) in adolescents on antipsychotic therapy. Specifics Aims 1. To determine if antipsychotic therapy leads to decreased bone mineral accrual and decreased bone mineral...
What is the current status of trial NCT00399776?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2006-10. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00399776?
The interventions under investigation include: Bone Density Test (RADIATION).
Who is sponsoring clinical trial NCT00399776?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.